Page last updated: 2024-11-11

escin ia

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

escin Ia: from seeds of Aralia elata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AraliagenusA plant genus in the family Araliaceae.[MeSH]AraliaceaeThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH]

Cross-References

ID SourceID
PubMed CID6476030
CHEMBL ID507233
MeSH IDM0296538

Synonyms (42)

Synonym
alpha-reparil
einecs 266-482-1
alpha-aescusan
ccris 7308
alpha-aescin
alpha-escin
ba 2672
2-butenoic acid, 2-methyl-, (3.beta.,4.beta.,16.alpha.,21.beta.,22.alpha.)-22-(acetyloxy)-3-[[o-.beta.-d-glucopyranosyl-(1->2)-o-[.beta.-d-glucopyranosyl-(1->4)]-.beta.-d-glucopyranuronosyl]oxy]-16,23,28-trihydroxyolean-12-en-21-yl ester, (2e)-
escine ia
(2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,
CHEMBL507233
escin ia
escin-ia
66795-86-6
.beta.-d-glucopyranosiduronic acid, (3.beta.,4.beta.,16.alpha.,21.beta.,22.alpha.)-22-(acetyloxy)-16,23,28-trihydroxy-21-(((2e)-2-methyl-1-oxo-2-buten-1-yl)oxy)olean-12-en-3-yl o-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-glucopyranosyl-(1->4))-
.alpha.-aescin
escin .alpha.-escin
escin .alpha.-escin [mi]
escin ia (constituent of horse chestnut) [dsc]
123748-68-5
LB5DJT9FIW ,
.alpha.-escin
aescin a
escin alpha-escin
beta-d-glucopyranosiduronic acid, (3beta,4beta,16alpha,21beta,22alpha)-22-(acetyloxy)-16,23,28-trihydroxy-21-(((2e)-2-methyl-1-oxo-2-buten-1-yl)oxy)olean-12-en-3-yl o-beta-d-glucopyranosyl-(1->2)-o-(beta-d-glucopyranosyl-(1->4))-
escin alpha-escin [mi]
unii-lb5djt9fiw
Q-100109
AKOS030530174
bdbm50478885
aescin ia
mfcd10566608
mfcd10566622
AC-34632
CS-0009081
HY-N0554
Q27282901
MS-31999
escin ia;aescin ia
EX-A6780
DTXSID701026284
escin ia (constituent of horse chestnut)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Upon clinical application of escin, adverse kidney reactions have been reported and the nephrotoxic mechanism responsible for this reaction remains elusive."( Computational and experimental characterization of isomers of escin-induced renal cytotoxicity by inhibiting heat shock proteins.
Shen, X; Sun, Y; Wang, Q; Wang, S; Yang, X; Zhang, X, 2021
)
0.62

Pharmacokinetics

Elin Ia increased in a dose-proportional manner at the dose of 0.5 mg/kg. After intravenous administration, the Cmax and AUC of escin Ia was increased.

ExcerptReferenceRelevance
" The method was successfully applied to a pharmacokinetic study of escins in healthy volunteers after oral administration of sodium aescinate tablets containing 60 mg escin saponins."( Simultaneous analysis of isomers of escin saponins in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study after oral administration.
Fawcett, JP; Gu, J; Liu, L; Sun, Y; Wang, Y; Wu, D; Wu, X; Zhang, J; Zhang, M, 2010
)
0.36
" The method was successfully employed in a pharmacokinetic study after a single intravenous infusion administration of sodium aescinate injection containing 10 mg escin to each of the 10 healthy volunteers."( A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of escin Ia and escin Ib in human plasma: application to a pharmacokinetic study after intravenous administration.
Cui, Y; Gu, J; Li, P; Liu, L; Sun, Y; Wang, Y; Wu, D; Wu, X; Yang, Y, 2010
)
0.58
"To establish a sensitive LC-MS/MS method and investigate the pharmacokinetic properties of escin Ia and isoescin Ia in rats and the pharmacokinetics difference of sodium escinate with pure escin Ia and isoescin Ia."( Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat.
Cui, XY; Fawcett, JP; Gao, F; Gu, JK; He, Q; Li, XJ; Wu, XJ; Zhang, JW; Zhang, ML, 2012
)
0.85
" Adequate pharmacokinetic data are essential for proper application of escin agent in clinical practice."( Pharmacokinetics of escin Ia in rats after intravenous administration.
Cui, XY; Gao, F; Gu, JK; Guan, X; Tian, LT; Wu, XJ, 2014
)
0.73

Bioavailability

ExcerptReferenceRelevance
" The absolute bioavailability of escin Ia and isoescin Ia and the bidirectional interconversion of them in vivo were also scarcely reported."( Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat.
Cui, XY; Fawcett, JP; Gao, F; Gu, JK; He, Q; Li, XJ; Wu, XJ; Zhang, JW; Zhang, ML, 2012
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protease Human immunodeficiency virus 1IC50 (µMol)35.00000.00000.81769.8500AID376377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1717738Cytotoxicity against African green monkey Vero E6 cells incubated for 2 days by the MTS assay2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
AID1717737Selectivity index, ratio of CC50 for African green monkey Vero E6 cells to EC50 for SARS-CoV infected in African green monkey Vero E6 cells2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
AID1717802Antiviral activity against SARS-CoV infected in African green monkey Vero E6 cells assessed as reduction in viral replication by ELISA2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
AID376377Inhibition of HIV1 protease1999Journal of natural products, Nov, Volume: 62, Issue:11
Anti-HIV-1 protease triterpenoid saponins from the seeds of Aesculus chinensis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's2 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.18 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]